Eagle is a fully integrated pharmaceutical company with research and development, clinical, manufacturing and commercial expertise. Eagle is committed to developing innovative medicines that result in meaningful improvements in patients’ lives. Eagle’s commercialized products include PEMFEXY®, RYANODEX®, BENDEKA®, BELRAPZO®, TREAKISYM® (Japan), and Byfavo® and Barhemsys® through its wholly owned subsidiary Acacia Pharma Inc. Eagle’s oncology and CNS/metabolic critical care pipeline includes product candidates with the potential to address underserved therapeutic areas across multiple disease states. Additional information is available on Eagle’s website at www.eagleus.com.
View Top Employees from Eagle Pharmaceuticals, Inc.Website | https://www.eagleus.com/ |
Ticker | EGRX |
Revenue | $195 million |
Funding | $50.2 million |
Employees | 158 (158 on RocketReach) |
Founded | 2007 |
Address | 50 Tice Blvd Ste 315, Woodcliff Lake, New Jersey 07677, US |
Phone | (201) 326-5300 |
Technologies |
JavaScript,
HTML,
PHP
+22 more
(view full list)
|
Industry | Pharmaceuticals, Pharmaceutical Manufacturing, Biotechnology, Healthcare, Science and Engineering, Drug Delivery, Health Care, Pharmaceutical |
Web Rank | 5 Million |
Keywords | Pharmaceutical Manufacturing, Clinical Research |
Competitors | Flexion Therapeutics, PANPHARMA, Sagent Pharmaceuticals, Supernus Pharmaceuticals, Inc., Xeris Pharmaceuticals, Inc. |
SIC | SIC Code 28 Companies, SIC Code 283 Companies |
NAICS | NAICS Code 32 Companies, NAICS Code 325413 Companies, NAICS Code 3254 Companies, NAICS Code 32541 Companies, NAICS Code 325 Companies |
Looking for a particular Eagle Pharmaceuticals, Inc. employee's phone or email?
The Eagle Pharmaceuticals, Inc. annual revenue was $195 million in 2024.
158 people are employed at Eagle Pharmaceuticals, Inc..
Eagle Pharmaceuticals, Inc. is based in Woodcliff Lake, New Jersey.
The NAICS codes for Eagle Pharmaceuticals, Inc. are [32, 325413, 3254, 32541, 325].
The SIC codes for Eagle Pharmaceuticals, Inc. are [28, 283].